Literature DB >> 17227768

MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance.

Karim Bouzakri1, Juleen R Zierath.   

Abstract

Tumor necrosis factor-alpha (TNF-alpha) induces skeletal muscle insulin resistance by impairing insulin signaling events involved in GLUT4 translocation. We tested whether mitogenic-activated protein kinase kinase kinase kinase isoform 4 (MAP4K4) causes the TNF-alpha-induced negative regulation of extracellular signal-regulated kinase-1/2 (ERK-1/2), c-Jun NH2-terminal kinase (JNK), and the insulin receptor substrate-1 (IRS-1) on the insulin signaling pathway governing glucose metabolism. Using small interfering RNA (siRNA) to suppress the expression of MAP4K4 protein 85% in primary human skeletal muscle cells, we provide evidence that TNF-alpha-induced insulin resistance on glucose uptake was completely prevented. MAP4K4 silencing inhibited TNF-alpha-induced negative signaling inputs by preventing excessive JNK and ERK-1/2 phosphorylation, as well as IRS-1 serine phosphorylation. These results highlight the MAPK4K4/JNK/ERK/IRS module in the negative regulation of insulin signaling to glucose transport in response to TNF-alpha. Depletion of MAP4K4 also prevented TNF-alpha-induced insulin resistance on Akt and the Akt substrate 160 (AS160), providing evidence that appropriate insulin signaling inputs for glucose metabolism were rescued. Silencing of MAP2K1 and MAP2K4, signaling proteins downstream of MAP4K4, recapitulated the effect of MAP4K4 siRNA in TNF-alpha-treated cells. Thus, strategies to inhibit MAP4K4 may be efficacious in the prevention of TNF-alpha-induced inhibitory signals that cause skeletal muscle insulin resistance on glucose metabolism in humans. Moreover, in myotubes from insulin-resistant type II diabetic patients, siRNA against MAP4K4, MAP2K4, or MAP2K1 restored insulin action on glucose uptake to levels observed in healthy subjects. Collectively, our results demonstrate that MAP4K4 silencing prevents insulin resistance in human skeletal muscle and restores appropriate signaling inputs to enhance glucose uptake.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17227768     DOI: 10.1074/jbc.M608602200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Discovery of an in Vivo Tool to Establish Proof-of-Concept for MAP4K4-Based Antidiabetic Treatment.

Authors:  Mark Ammirati; Scott W Bagley; Samit K Bhattacharya; Leonard Buckbinder; Anthony A Carlo; Rebecca Conrad; Christian Cortes; Robert L Dow; Matthew S Dowling; Ayman El-Kattan; Kristen Ford; Cristiano R W Guimarães; David Hepworth; Wenhua Jiao; Jennifer LaPerle; Shenping Liu; Allyn Londregan; Paula M Loria; Alan M Mathiowetz; Michael Munchhof; Suvi T M Orr; Donna N Petersen; David A Price; Athanasia Skoura; Aaron C Smith; Jian Wang
Journal:  ACS Med Chem Lett       Date:  2015-10-06       Impact factor: 4.345

2.  Chronically increased S6K1 is associated with impaired IRS1 signaling in skeletal muscle of GDM women with impaired glucose tolerance postpartum.

Authors:  Linda A Barbour; Carrie E McCurdy; Teri L Hernandez; Jacob E Friedman
Journal:  J Clin Endocrinol Metab       Date:  2011-02-02       Impact factor: 5.958

3.  Downregulation of Grb2 contributes to the insulin-sensitizing effect of calorie restriction.

Authors:  Xianling Liu; Meilian Liu; Jingjing Zhang; Xiang Bai; Fresnida Ramos; Holly Van Remmen; Arlan Richardson; Fu-You Liu; Lily Q Dong; Feng Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-02-24       Impact factor: 4.310

Review 4.  Promoting longevity by maintaining metabolic and proliferative homeostasis.

Authors:  Lifen Wang; Jason Karpac; Heinrich Jasper
Journal:  J Exp Biol       Date:  2014-01-01       Impact factor: 3.312

5.  Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.

Authors:  Andrew H Miller
Journal:  Brain Behav Immun       Date:  2008-09-03       Impact factor: 7.217

Review 6.  Map4k4 Signaling Nodes in Metabolic and Cardiovascular Diseases.

Authors:  Joseph V Virbasius; Michael P Czech
Journal:  Trends Endocrinol Metab       Date:  2016-05-06       Impact factor: 12.015

Review 7.  Cytokines and glucocorticoid receptor signaling. Relevance to major depression.

Authors:  Thaddeus W W Pace; Andrew H Miller
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

8.  Effects of rosiglitazone on inflammation in Otsuka long-evans Tokushima Fatty rats.

Authors:  Jin Woo Lee; Il Seong Nam-Goong; Jae Geun Kim; Chang Ho Yun; Se Jin Kim; Jung Il Choi; Young Il Kim; Eun Sook Kim
Journal:  Korean Diabetes J       Date:  2010-06-30

Review 9.  The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD).

Authors:  Qing Liu; Stig Bengmark; Shen Qu
Journal:  Lipids Health Dis       Date:  2010-04-28       Impact factor: 3.876

10.  Regulation of skeletal muscle sucrose, non-fermenting 1/AMP-activated protein kinase-related kinase (SNARK) by metabolic stress and diabetes.

Authors:  A Rune; M E Osler; T Fritz; J R Zierath
Journal:  Diabetologia       Date:  2009-08-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.